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Abstract 
 
West Nile virus (WNV), a positive sense single stranded RNA flavivirus, is 
prevalent in many countries worldwide and is a growing threat in the United States. Some 
patients infected with WNV develop severe neuroinvasive disease including meningitis 
or encephalitis which may lead to death. The recently characterized cytokine interleukin-
17 (IL-17) has been implicated in several autoimmune diseases, neuroinflammatory 
conditions, and immune responses to various microbial infections. Previous research has 
indicated that a known contributor to IL-17 production, interleukin-23, is produced in 
response to WNV infection, but the role of IL-17 during WNV infection has not been 
studied before. This study found that WNV infected IL-17 deficient (IL-17-/-) mice 
developed higher viral loads in the blood and brain compared to wild-type (WT) control 
mice and were susceptible to severe WNV infection (IL-17-/- 20% survival; WT 60% 
survival). Interestingly, CD8+ T cells isolated from IL-17-/- mice infected with WNV 
showed reduced cytotoxicity compared to WT CD8+ T cells. These results suggest that 
IL-17 plays a protective role during WNV infection by contributing to the cytotoxicity of 
CD8+ T cells. CD8+ T cells have previously been shown to play a protective role during 
WNV infection, but little is known about the activation CD8+ T cells or their recruitment 
to WNV infected cells. Further studies are warranted to elucidate the mechanism by 
which IL-17 signaling regulates CD8+T cell responses during WNV infection. 
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Chapter 1: The Problem 
West Nile virus (WNV) is an emerging viral infection worldwide and a 
growing threat in North America. WNV is primarily maintained through avian-mosquito 
transmission cycles and transmitted to human hosts by the bite of an infected mosquito. 
Once inside the human body, WNV can cause a number of symptoms that may range 
from minor febrile illness to fatal encephalitis. WNV poses a more serious threat to older 
and immunocompromised patients in which the disease often presents as fatal 
encephalitis. Currently, there is no specific antiviral drug or vaccine available to treat 
WNV infections in humans. In addition, the pathogenesis of WNV infection and the role 
of the host immune system are still not adequately investigated. Understanding of the 
host’s defense mechanisms to fight WNV infection can lead to the development of novel 
therapeutics and vaccines. 
 The immune system responds to WNV infection in a number of ways. 
Among various innate and adaptive immune effector mechanisms, CD8+ T cells play a 
prominent role in combating viral infections. Previous studies have shown that CD8+ T 
cells play an important role in the clearance of WNV and protection from fatal WNV 
infection. These cytotoxic CD8+ T cells act via targeted killing of WNV infected cells 
using various mechanisms including Fas-Fas Ligand (Fas-FasL) interaction and the 
release of preformed cytotoxic granules. However, the exact mechanism of CD8+ T cell 
activation, recruitment to infection sites, and virus clearance is not completely understood 
and requires further study. 
 Several components of the immune system, including cytokines and 
chemokines, are produced during infection and determine fate of CD8+ T cells. This 
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includes the activation, migration and cytotoxic functions of these cells. It has been 
demonstrated that a newly characterized cytokine, interleukin-17 (IL-17), plays an 
important role in most immune responses by promoting inflammation and recruiting 
neutrophils. In addition, studies have shown that cells involved in production of IL-17 
contribute to clearance of other viruses and intracellular pathogens.  
A population of CD8+ T cell (called Tc17), which produce IL-17, has been 
shown to provide protection during influenza virus infection. Tc17 cells have been found 
to secrete IL-17 during vaccinia virus and hepatitis C virus infection, as well. In addition, 
IL-17 has been found to promote CD8+ T cell activation during infection with the 
intracellular bacteria Listeria monocytogenes. However, the role played by IL-17 has not 
previously been studied in relation to WNV infection. Preliminary studies in Dr. Fengwei 
Bai's laboratory have shown that IL-17 deficient (IL-17-/-) mice are more susceptible to 
WNV infection compared to wild-type mice. It follows that IL-17 could play a role 
during the CD8+ T cell mediated immune response to WNV. Therefore, I hypothesized 
that IL-17 plays a role in the CD8+ T cell mediated immune response to WNV.  IL-17 is 
produced by several immune cells including γδ T cells and Th17 cells. IL-17 is shown to 
be produced during WNV infection, and γδ T cells, a major source of IL-17 during 
infection, play a protective role against WNV infection. Whether IL-17 producing CD8+ 
T cells function in clearing WNV infections or IL-17 produced by other cell types aid in 
the activation and migration of CD8+ T cell has not been described during WNV 
infection. 
 In order to elucidate the function of IL-17 in controlling CD8+ T cell 
function, a mouse model of WNV infection (wild-type (WT) and IL-17 -/- mice) was 
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used. To this end, the research planned to fill in some of the unknown areas in CD8+ T 
cell mediated clearance of WNV including the role of IL-17 in the activation and 
cytotoxic function of the CD8+ T cells. This research also aimed to identify a previously 
undescribed function of IL-17 in protecting against severe WNV infection through 
activation of CD8+ T cells. This novel IL-17-CD8+ T cell axis may be applicable to 
further understanding of WNV pathogenesis and to development of novel therapeutics. 
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Chapter 2: Literature Review 
2.1: Background 
 West Nile Virus (WNV) is a positive sense, single-stranded RNA (+ssRNA) 
flavivirus. It was first discovered in Uganda in 1937, and has since been reported in many 
countries around the world. The first instances of WNV infection in the United States 
were found in 1999, and the virus quickly spread across the country (Brault, 2009). The 
North American strain is highly infectious and causes a high viremia in birds. This strain 
also seems to be more virulent than the strain originally discovered in Africa (Brault, 
2009). WNV is maintained in an avian-mosquito transmission cycle and is transmitted 
from birds to humans via infected mosquito vectors of the Culex genus (Wertheimer, 
2012; Brault, 2009). The transmission cycle of WNV is shown (Fig. 1). 
 
Figure 2.1. The transmission cycle of WNV. Primary transmission cycle shown in 
black, incidental hosts shown in blue. (Adapted from Brault (2009), p. 47) 
 
 In humans, most infections with WNV are asymptomatic and do not require 
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treatment (Sitati & Diamond, 2006). However, symptoms vary widely among patients, 
and in some cases, infection can cause meningitis, encephalitis, paralysis, or even death 
(Sejvar et al., 2003). In young patients, infection generally presents as West Nile fever 
(Brault, 2009). WNV can also invade the central nervous system (CNS) in less than 1% 
of patients, usually elderly or immunocompromised individuals, and lead to severe 
neurologic symptoms (Sejvar et al., 2003). Due to the possibility of severe symptoms, 
more knowledge of the mechanisms of WNV infection and the immune response is 
needed in order to provide optimal healthcare to infected patients. 
2.2: WNV Pathogenesis and Immunity 
 After inoculation through the bite of an infected mosquito, WNV is thought 
to infect the Langerhans cells in the skin (a type of dendritic cell) then move to the lymph 
nodes. After one week, the virus can be detected in the CNS in some infected patients 
(Samuel & Diamond, 2006). WNV causes apoptosis of host cells and by this mechanism 
can cause death of the host, especially when cells of the CNS are infected (Wang et al., 
2006). In a mouse model of WNV infection, Wang et al. (2003) found that virus can be 
isolated from lymphoid tissues 4-5 days after infection and can be isolated from the brain 
7 days after infection, when a dose is administered at a similar size to that of a mosquito 
vector bite. Though it is mainly passed through arthropod vectors, it is possible to pass 
the virus by infected organ transplant or whole blood donation without proper screening 
for WNV (Rhee et al., 2011). No vaccine has been approved for human use, though there 
are equine vaccines available. Currently the most effective means of controlling WNV in 
humans is through control of the mosquito population (Wertheimer, 2012). Therefore, 
development of effective clinical strategies is critical to combating WNV infection in 
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humans. 
 Inside the host's body, WNV elicits a response from both the innate and 
adaptive immune systems. In the innate immune response, viral sensors in many cell 
types detect viral ribonucleic acid resulting in activation of interferon (IFN) and other 
transcription factors. IFNs provide direct antiviral responses and further stimulate 
dendritic cell (DC) maturation. DCs can then activate B and T lymphocytes through 
antigen presentation (Samuel & Diamond, 2006). Several innate immune cells including 
macrophages, γδ T cells, and natural killer cells directly kill WNV infected cells (Samuel 
& Diamond, 2006). While these innate immune mechanisms respond during the early 
period, the adaptive immune response develops later to further control WNV infection.  
In the adaptive immune response, B lymphocytes produce antibodies IgM and 
IgG, which control viremia and inhibit further dissemination to CNS. These antibodies 
are thought to neutralize the virus, blocking its entry into host cells (Samuel & Diamond, 
2006). Similarly, CD4+ or CD8+ T lymphocytes also provide immunity to WNV 
infection and play an important role in host recovery. CD4+ T cells act by priming of 
CD8+ T cells, secretion of cytokines, activation of B cells, and direct cytotoxicity. CD8+ 
T cells respond to WNV infection by secretion of inflammatory cytokines and direct 
killing of infected cells. All of these lymphocytes also contribute to memory responses in 
future WNV infections (Samuel & Diamond, 2006). An overview of the adaptive 
immune response to virus infection is given (Fig. 2). 
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Figure 2.2. Adaptive immune response to virus infection. (Adapted from De Haes 
(2012), p. 31) 
 
2.3 Role of CD8+ T Cells during WNV Infection 
 CD8+ T cells, also referred to as cytotoxic T lymphocytes, play a critical role 
in control of WNV infection. These are comprised of both effector cells that directly fight 
the current virus infection and memory cells that aid the body in fighting future infections 
(Cox et al., 2013). According to Shrestha and Diamond (2004) mice that lack normal 
levels of CD8+ T cells are more likely to die from WNV infection, indicating that these 
cells are important to WNV clearance. CD8+ T cells combat WNV infection in several 
ways including release of cytotoxic granules, Fas-FasL interaction, production of 
antiviral cytokines and tumor necrosis factor alpha (Shrestha & Diamond, 2007), but 
evidence has shown that they may also utilize other killing methods. 
 In a study of the progression and clearance of WNV, Wang et al. (2003) 
found that CD8+ T cells were the dominant type of lymphocyte that homed to the brain 
after WNV infection. From their findings, the group concluded that CD8+ T cells have an 
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important role in WNV infection. Shrestha and Diamond (2004) also confirmed that 
CD8+ T cells play a crucial role in clearance of WNV and use a perforin dependent 
mechanism to clear WNV from host tissues (Shrestha et al., 2006). However, CD8+ T 
cells do not use perforin alone to stop the replication of WNV in host cells. Fas-FasL 
interaction was found to be used by CD8+ T cells in addition to the perforin mechanism 
(Shrestha & Diamond, 2007). The Fas-FasL mechanism was found to be subordinate to 
the perforin mechanism and more tissue specific (Shrestha & Diamond, 2007). 
These findings confirm that CD8+ T cells play a vital role in the host's 
response to WNV. Both the perforin and Fas-FasL mechanisms do not show strong 
phenotypes in WT animals compared to those in CD8+ T cell deficient animals, 
suggesting that other mechanisms also play a role in CD8+ T cell mediated clearance of 
WNV infection. Although the role of CD8+ T cell during WNV infection is mostly 
understood, little is known about the mechanisms of CD8+ T cell activation and 
recruitment to infection sites. Further study is needed to fully elucidate the method of 
CD8+ T cell activation and recruitment during WNV infection. 
2.4: Role of IL-17 in CD8+ T cell Function 
 The activation and differentiation of antiviral CD8+ T cells is controlled by a 
number of intracellular signaling molecules called cytokines (Cox et al., 2013). It has 
been found in the Bai laboratory that IL-17-/- mice are more susceptible to WNV 
infection than WT mice (Unpublished data). IL-17 is produced by a number of immune 
cells including Tc17, a subset of CD8+ T cells, and Th17 cells, a subset of CD4+ T cells 
(Hamada et al., 2009). Other cells that produce IL-17 include γδ T cells, natural killer 
cells, natural killer T cells, neutrophils, and eosinophils (Korn et al., 2009). These cells 
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span over both innate and adaptive immunity, making IL-17 active in both systems (Korn 
et al., 2009).  
 Cells that produce IL-17 are known to act by promoting inflammation, 
promoting hematopoiesis, and recruiting neutrophils (Hamada et al., 2009). However, 
some evidence has shown that IL-17 also plays an important role in the adaptive immune 
system through the homing of activated CD4+ Th1 cells and CD8+ T cells to infection 
sites. In addition, Tc17 cells that produce IL-17 have been found to aid in clearance of 
vaccinia virus in a mouse model, as well as use an interferon gamma dependent 
mechanism to clear influenza virus (Yeh et al., 2010; Hamada et al., 2009).  
A similar effect was found in hepatitis C infection, another member of the 
flaviviridae family, along with WNV, where Tc17 cells home to the liver and secrete IL-
17 while playing a role in hepatitis C virus clearance (Billerbeck et al., 2010).  However, 
it has been shown that Tc17 cells do not produce perforin and use no other means of 
direct cytotoxicity (Hamada et al., 2009). These findings led to the conclusion that the 
Tc17 cell functions in the recruitment of other host cells, including CD8+ T cells, instead 
of acting through direct cytotoxicity (Hamada et al., 2009). Even so, the influence of IL-
17 on CD8+ T cells during WNV infection has not been studied. It is possible that IL-17 
plays a role in CD8+ T cell mediated immunity during WNV infection. 
 Besides this, IL-17 has also been found to contribute to the activation of 
CD8+ T cells. IL-17 is known to be produced by γδ T cells during innate immune 
response to WNV infection, but little is known about its role in the activation of CD8+ T 
cells. During L. monocytogenes infection, a subset of γδ T cells which produce IL-17 
contribute to the proliferation of CD8+ T cells through enhanced cross presentation of 
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antigens by DCs (Xu et al., 2010). CD8+ T cells are able to respond to the antigens 
presented on the DCs and become activated to carry out cytotoxic effects. Xu et al. 
(2010) also suggested that Th17 cells, which are one of the cellular sources of IL-17, aid 
in proliferation of CD8+ T cells, but the method of which is not fully understood and 
requires further study. This indicates that the IL-17 produced by other cell types may play 
a role in proliferation and activation of CD8+ T cells during WNV infection. Further 
study is required to confirm this hypothesis. 
2.5: Hypothesis 
 CD8+ T cells are known to be important in the body's defense mechanisms 
against WNV. Further study is required to fully understand the activation and 
differentiation of these cells. IL-17 has been shown to be effective in CD8+ T cell 
mediated clearance of other viruses and intracellular pathogens and has been shown to 
affect the activation of CD8+ T cells. Therefore, it follows that IL-17 may influence the 
function of CD8+ T cells during WNV infection, as well. Based on these findings, I 
predicted that IL-17 could play an important role in CD8+ T cell mediated clearance of 
WNV and tested this hypothesis by comparing the cytotoxicity of CD8+ T cells isolated 
from WT and IL-17-/- mice. If this IL-17/CD8+ T cell axis is confirmed, the mechanism 
by which the IL-17 stimulated CD8+ T cells combat WNV can be studied further. These 
findings will aid in further understanding of the pathogenesis of WNV and other viruses 
which may inform advances in treatments and other therapeutics, as well as in vaccine 
technology. 
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Chapter 3: Methodology 
3.1 Mice and Infection 
  WT and IL-17-/- mice (C57BL/6) were challenged with WNV isolate 2471 
in an animal Biosafety Level 3 (BSL3) facility by BSL3 certified personnel. The virus 
stock preparation and a subsequent plaque assay in Vero cells were used to determine the 
titer of the virus. All animals were handled in a BSL3 animal facility in accordance with 
protocols approved by the University of Southern Mississippi Institutional Animal Care 
& Use Committee. 
3.2 Survival Analysis 
 WT and IL-17-/- mice (7 week, sex matched)  were challenged via 
intraperitoneal (i.p) injection of 1000 plaque forming units (PFU) of WNV in 100 µl of 
PBS with 1% gelatin. Mice are observed twice daily for mortality and morbidity up to 21 
days postinfection (p.i.). This survival study was also performed using a footpad infection 
route. 
3.3 Quantitation of Viral Load 
 After day 4 and day 6 p.i. with WNV infection, blood and brain specimens 
were obtained from WT and IL17-/- mice. Total RNA was extracted by using RNeasy 
Mini Kit (Quigen) and complementary DNA (cDNA) was prepared using iScript cDNA 
synthesis kit (Biorad). WNV-E and cellular β- actin gene RNA copy numbers were 
measured by quantitative polymerase chain reaction (qPCR) using SYBR Green 
Supermix (Biorad). The viral load in each specimen was expressed as ratio of WNV-E 
copy number to that of cellular β- actin. Primers used for qPCR were previously 
 12 
 
described (Bai et al., 2009). 
3.4 Cell Culture 
 MC57GL cells expressing amino acids 1 through 402 of the WNV E protein 
through  pcDNA3.1 vector (MC57GLWNV-E ) or pcDNA3.1 vector only (MC57GLvector), 
were used as a generous gift from Michael S. Diamond (Washington University in St. 
Louis, School of Medicine). Both MC57GLWNV-E and MC57GLvector cells were 
maintained in Dulbecco's Modified Eagle Medium (DMEM) with 5% fetal bovine serum 
(FBS) and 50 μM β-mercaptoethanol. 
3.5 CD8+ T cell Isolation 
 Mice infected with WNV (100 PFU) were sacrificed at day 10 p.i. by CO2 
inhalation and spleens were collected in RPMI media. After isolation of the splenocyte 
population, cells were subjected to CD8+ T cell isolation by negative selection with 
magnetic beads using Mouse CD8+ T Lymphocyte Enrichment Set - DM (BD 
Biosciences). Isolated CD8+ T cells were confirmed using CD45 and CD8α (Ly-2) 
antibodies and subjected to cytotoxicity testing. 
3.6 Cytotoxicity Assays 
The cytotoxicity of isolated CD8+ T cells was determined as described by 
Shrestha and Diamond (2004) with minor modifications. MC57GL WNV-E and 
MC57GLvector cells served as WNV specific target cells and control cells, respectively. 
WNV effector CD8+ T cells isolated from both WT and IL-17-/- mice were plated in 96 
well plates along with MC57GLWNV-E or MC57GLvector in a 1:100 ratio and tested for 
their ability to lyse the target cells. The lysis of the target cells was detected using 
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Cytotoxicity Detection Kit (LDH) according to the instructions of the manufacturer 
(Thermo Scientific). This method determined the percentage of cell lysis by colorimetric 
measurement of lactate dehydrogenase (LDH) released by the lysed cells.  
3.7 Data Analysis 
 Data collected were organized and maintained in standard excel spreadsheets 
and analyzed using Prism 6 software (GraphPad). ANOVA and t-test were also used 
whenever applicable. A value of α ≤0.05 was assumed to be significant. Survival data 
were analyzed using the Kaplan-Meier survival and log-rank test (GraphPad Prism 
software, version 6.0). The significant variation in cytotoxicity between WT and IL-17-/- 
mice was interpreted as an indication of CD8+ T cell involvement in an IL-17 dependent 
manner during WNV infection. 
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Chapter 4: Results 
4.1 IL-17-/- Mice Are Susceptible to Lethal WNV Infection 
The mortality of WT and IL-17 -/- mice when infected with WNV was 
compared using both i.p. and footpad infection routes. Survival rates were significantly 
lower in IL-17 -/- animals than in WT for both injection routes (Fig. 4.1A and B).  About 
60% of WT mice survived WNV challenge via i.p. injection compared to about 20% of 
IL-17 -/- mice. Similarly, in footpad inoculation, about 60% of WT mice survived 
compared to about 10% of IL-17 -/- mice. Collectively, these data suggest that IL-17 
plays a protective role during WNV infection. 
 A.     B.    
            
Figure 4.1. Survival analysis for WT and IL-17 -/- mice inoculated with WNV. Mice 
(7 weeks old, sex matched) were infected with 1000 PFU of WNV and monitored twice 
daily for survival. Survival data were analyzed by log rank test. (A) Survival data of WT 
and IL-17 -/- mice inoculated via i.p. injection. (B) Survival data of WT and IL-17 -/- 
mice inoculated via footpad injection.  
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4.2 IL-17-/- Mice Develop Increased Viral Load in Blood and Brain 
 After WNV infection, viral loads in the blood and brain of both WT and IL-
17-/- mice were measured using qPCR. At day four, the viral load in the blood of IL-17-/- 
mice was much higher than that in the WT mice (Fig.4.2A). Similarly, the viral load in 
the brain at day seven was much higher in IL-17-/- mice than in WT mice (Fig. 4.2B). 
These data suggest that IL-17 plays an important role in controlling both viremia and 
WNV replication in brain. 
                   A.               B. 
                                              
Figure 4.2. IL-17-/- mice produce high viral load in blood and brain. WT and  
IL-17-/- mice were infected with 1000 PFU of WNV. (A) Blood collected at day 4 was 
analyzed for WNV RNA copy number by qPCR. (B) Viral load in brain was analyzed at 
day 7 by qPCR.   
 
4.3 Cytotoxicity of CD8+ T cells 
 Previous studies have shown that CD8+ T cells play an important role in 
clearance of WNV and protection from fatal WNV infection. In order to assess the effect 
of IL-17 on CD8+ T cells, the cytotoxicity of WNV primed CD8+ T cells from WT and 
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IL-17-/- mice was tested against target cells expressing WNV E protein. A significant 
reduction in killing of WNV specific target cells (MC57GLWNV E) by CD8+ T cells 
isolated from IL-17-/- mice was detected when compared to WT CD8+ T cells (Fig. 4.4). 
As expected, WT and IL-17-/- CD8+ T cells had approximately the same level of 
cytotoxicity against control cells (MC57GLvector). These results suggest that IL-17 plays 
an important role in CD8+ T cell mediated clearance of WNV. 
 
Figure 4.3. Cytotoxicity of WT and IL-17-/- CD8+ T cells. WT and IL-17-/- mice were 
infected with 100 PFU of WNV through i.p. route. Spleens were collected at day 10 post 
infection and subjected to CD8+ T cell isolation using magnetic beads. Purified CD8+ T 
cells were mixed with WNV specific target (MC57GLWNV E) or control (MC57GLvector) 
cells in 1: 100 ratios (target to effector) and incubated at 37˚C. After 4 hours of 
incubation, the lactate dehydrogenase (LDH) released from lysed cells was detected using 
an LDH cytotoxicity detection kit and the percentage of cytotoxicity was calculated. 
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Chapter 5: Discussion  
The proinflammatory cytokine IL-17 is known to play an important role in 
development of neutrophils and their recruitment to infection sites, and has been linked to 
several autoimmune and inflammatory diseases (Korn et al., 2009; Nakae et al., 2003; 
Langrish et al., 2005). In addition, IL-17 has been implicated in several microbial 
infections including Klebsiella pneumoniae, Bordetella pertussis, Mycoplasma 
pneumoniae, and Mycobacterium tuberculosis, and Candida albicans (Korn et al., 2009) 
and in inflammation of the CNS, including experimental autoimmune encephalitis 
(Komiyama et al., 2006), but its role during WNV infection has not been studied before.  
Cytokine interleukin-23 (IL-23) plays an important role in the development of Th17 cells, 
a major cell type producing IL-17. It is previously shown that an IL-23 response is 
induced during WNV infection via a Toll-like receptor 7 (TLR7) dependent pathway 
(Town et al., 2008), suggesting that IL-17 might play a role in the immune response to 
WNV. This study aimed to assess whether IL-17 plays a role during WNV immunity. 
The survival of IL-17 -/- mice studied against WT mice in response to lethal WNV 
challenge showed that the number of mice that survived after WNV challenge was much 
lower in the IL-17-/- compared to that of the WT mice (Fig. 4.1A and B). Consistent with 
reduced survival, viral load in the blood and brain of IL-17-/- mice was significantly 
higher when compared to WNV infected WT mice (Fig. 4.2A and B). The increased viral 
loads found in IL-17-/- mice indicate that IL-17-/- mice are less capable of controlling 
WNV, suggesting a protective role of IL-17 during WNV infection. Supporting this 
result, IL-17 is known to play a protective role during several other viral infections 
including influenza and vaccinia viruses (Hamada et al., 2009; Yeh et al., 2010). A 
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protective role of IL-17 in several fungal and bacterial infections has been previously 
reviewed, as well (Curtis & Way, 2009; Bar et al., 2014). 
 It is previously reported that cytotoxic CD8+ T cells play an important role in 
clearance of WNV infection (Shrestha & Diamond, 2004; Wang et al., 2003). The 
primary methods of killing utilized by the CD8+ T cells are both a perforin dependent 
mechanism and a Fas-FasL interaction, both of which result in apoptosis of WNV 
infected cells (Shrestha et al., 2006; Shrestha & Diamond, 2007). However, the 
mechanism of CD8+ T cell activation and cytoxicity during WNV infection is not clearly 
understood.  This study tested the possible role of IL-17 in CD8+ T cell function during 
WNV infection by subjecting CD8+ T cells collected from WNV infected IL-17-/- mice 
to a cytotoxicity assay. The cytotoxicity assay showed a reduced level of cytotoxicity in 
the CD8+ T cells isolated from IL-17-/- mice compared to WT CD8+ T cells (Fig. 4.4). 
The reduced cytotoxicity exhibited by the IL-17-/- CD8+ T cells indicates that IL-17 
plays a role in the cytotoxic ability of the CD8+ T cells. Based on these findings, it 
follows that IL-17 produced during WNV infection might play a role in the CD8+ T cell 
mediated clearance of the virus. Although the role of IL-17 in CD8+ T cell cytotoxicity 
was not previously understood, the possible connection between CD8+ T cells and IL-17 
had been suggested (Billerbeck et al., 2010; Yeh et al., 2010; Xu et al., 2010). A 
population of CD8+ T cells called Tc17, which produce IL-17, has been shown to 
provide protection during influenza virus infection (Hamada et al., 2009), vaccinia virus 
infection (Yeh et al., 2010) and hepatitis C virus infection (Billerbeck et al., 2010). 
Similarly, IL-17 produced by γδ T cells has been found to promote CD8+ T cell 
activation during infection with the intracellular bacteria L. monocytogenes (Xu et al., 
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2010). 
 In conclusion, this study suggests that IL-17 plays an important role in the 
immune response to WNV infection. IL-17 is likely produced in response to IL-23 after 
detection of viral ssRNA by TLR7 and contributes to the cytotoxicity of CD8+ T cells 
during the adaptive immune response. This result provides a novel role of IL-17 in the 
adaptive immune response to WNV infections. In future studies, the precise mechanism 
by which IL-17 controls the cytotoxicity of CD8+ T cells will need to be elucidated. 
Since IL-17 can be produced by many different cell types and might possibly regulate 
CD8+ T cell biology at many different stages including development and function, 
further research is warranted for a complete understanding of the role of IL-17 in the 
immune response to WNV infection. 
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